Lexeo Therapeutics, Inc. (LXEO)

Lexeo Therapeutics, Inc. (LXEO) is a healthcare company (biotechnology) based in the United States. The share price is $3.11, down 3.72% on the day, which values the company at $255.29M. Price as of 17 Nov 2026, 17:36 UTC, from Yahoo Finance.

Key facts

Share price
$3.11−3.72% today
Market value
$255.29M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Lexeo Therapeutics, Inc. in more detail

LXEO trades at -2.1× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Thin interest cover.

1 of the superinvestors tracked here hold LXEO, including Peter Kolchinsky (0.2% of the portfolio).

Superinvestors holding LXEO

1 of the investors tracked here report a position in their latest 13F filing.

Lexeo Therapeutics, Inc. (LXEO): questions and answers

What is Lexeo Therapeutics, Inc.'s market cap?

Lexeo Therapeutics, Inc. is valued at $255.29M at a share price of $3.11.

Does LXEO pay a dividend?

Lexeo Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own LXEO?

In their latest quarterly filings, Peter Kolchinsky (0.2% of the portfolio) hold LXEO. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Lexeo Therapeutics, Inc. (LXEO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/LXEO

Underlying data: Yahoo Finance; company filings with the SEC.